~~Registrant's~~Registrant’s telephone number, including area code: (561) 491-9595

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, and an “emerging growth company” in Rule 12b-2 of the Exchange Act.

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition 13(a) of the Securities Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date. As of ~~May 17, 2021,~~February 12, 2022, the Registrant had outstanding ~~287,807,041~~364,278,386 shares of common stock.

This document contains certain statements of a forward-looking nature. Such forward-looking statements, including but not limited to statements regarding projected growth, trends and strategies, future operating and financial results, financial expectations and current business indicators are based upon current information and expectations and are subject to change based on factors beyond the control of the Company. Forward-looking statements typically are identified by the use of terms such as “look,” “may,” “should,” “might,” “believe,” “plan,” “expect,” “anticipate,” “estimate” and similar words, although some forward-looking statements are expressed differently. The accuracy of such statements may be impacted by a number of risks and uncertainties that could cause actual results to differ materially from those projected or anticipated, including but not limited to those set forth herein and in our Annual Report on Form 10-K.

Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. Except as required by the federal securities laws, we undertake no obligation to update forward-looking information. Nonetheless, the Company reserves the right to make such updates from time to time by press release, periodic report or other method of public disclosure without the need for specific reference to this Report. No such update shall be deemed to indicate that other statements not addressed by such update remain correct or create an obligation to provide any other updates.

XERIANT, INC.
XERIANT, INC. AND SUBSIDIARY								XERIANT, INC. AND SUBSIDIARY
CONDENSED CONSOLIDATED BALANCE SHEETS	CONDENSED CONSOLIDATED BALANCE SHEETS							CONDENSED CONSOLIDATED BALANCE SHEETS

		As of March 31, 2021 (Unaudited)			As of June 30, 2020				As of December 31, 2021			As of June 30, 2021
Assets									(Unaudited)
Current assets
Cash		$	1,506,566		$	38,893		Cash	$	2,110,549		$	962,540
Deposits			62,000			-				12,546			12,546
Prepaids			14,351			13,893				2,823			1,234
Total current assets			1,582,917			52,786				2,125,918			976,320

Property & equipment, net										4,907
Operating lease right-of-use asset			178,786			206,111				149,310			169,209
Total assets		$	1,761,703		$	258,897			$	2,280,135		$	1,145,529

Liabilities & stockholders' deficit
Liabilities & stockholders’ deficit
Current liabilities
Accounts payable and accrued liabilities		$	18,740		$	27,621			$	23,744		$	73,224
Accrued liabilities, related party			27,000			9,000				30,000			25,000
Convertible notes payable, net of discount			102,920			32,734				721,055			158,196
Lease liability, current			41,165			36,963				45,720			42,643
Total current liabilities			189,825			106,318				820,519			299,063

Lease liability, long-term			152,370			183,803				117,585			141,160
Total liabilities			342,195			290,121				938,104			440,223

Commitments and contingencies (Note 9)
Commitments and contingencies (Note 8)										-			-

Stockholders' deficit
Series A Preferred stock, $0.00001 par value; 100,000,000 authorized; 3,500,000 designated; 793,279 and 3,113,638 shares issued and outstanding at March 31, 2021 and June 30, 2020, respectively			8			31
Common stock, $0.00001 par value; 5,000,000,000 shares authorized; 283,875,576 and 69,584,149 shares issued and outstanding at March 31, 2021 and June 30, 2020, respectively			2,836			696
Stockholders’ deficit
Series A Preferred stock, $0.00001 par value; 100,000,000 authorized; 3,500,000 designated; 781,132 and 793,279 shares issued and outstanding at December 31, 2021 and June 30, 2021, respectively										8			8
Series B Preferred stock, $0.00001 par value; 100,000,000 authorized; 1,000,000 designated; 1,000,000 shares issued and outstanding at December 31, 2021 and June 30, 2021, respectively										10			10
Common stock, $0.00001 par value; 5,000,000,000 shares authorized; 358,202,770 and 292,815,960 shares issued and outstanding at December 31, 2021 and June 30, 2021, respectively										3,577			2,925
Common stock to be issued			298,000			372,397				347,900			51,090
Additional paid in capital			3,757,847			379,971				14,451,855			4,138,194
Accumulated deficit			(2,639,183	)		(784,319	)			(10,029,764	)		(3,270,235	)
Total stockholders' deficit			1,419,508			(31,224	)
Total liabilities and stockholders' deficit		$	1,761,703		$	258,897
Total Xeriant stockholder’s deficit										4,773,586			921,992
Non-controlling interest										(3,431,555	)		(216,686	)
Total stockholders’ deficit										1,342,031			705,306
Total liabilities and stockholders’ deficit									$	2,280,135		$	1,145,529

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

XERIANT, INC.
XERIANT, INC. AND SUBSIDIARY														XERIANT, INC. AND SUBSIDIARY
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS	CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS													CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(UNAUDITED)	(UNAUDITED)													(UNAUDITED)

		For the three months ended						For the nine months ended							For the three months ended			For the three months ended			For the six months ended
		March 31, 2021			March 31, 2020			March 31, 2021			March 31, 2020				December 31, 2021			December 31, 2020			December 31, 2021			December 31, 2020

Operating expenses:
Sales and marketing		$	-		$	-		$	1,000,000		$	-
General and administrative			141,897			73,409			242,445			141,945
Sales and marketing expense															$	46,623		$	1,027,109		$	645,218		$	1,027,109
General and administrative expenses																1,120,250			37,469			2,321,252			73,439
Professional fees			32,160			48,250			67,397			114,668				102,484			14,637			132,025			35,237
Consulting fees – related party			54,500			-			132,500			-
Research and development			-			-			-			6,339
Related party consulting fees																130,925			41,500			213,425			78,000
Research and development expense																2,859,644			0			5,200,219			0
Total operating expenses			228,557			121,659			1,442,342			262,952				4,259,926			1,120,715			8,512,139			1,213,785

Operating loss			(228,557	)		(121,659	)		(1,442,342	)		(262,952	)			(4,259,926	)		(1,120,715	)		(8,512,139	)		(1,213,785	)

Other expenses:
Amortization of debt discount			(103,225	)		(152,423	)		(215,635	)		(286,375	)			(1,264,931	)		(66,449	)		(1,413,959	)		(112,410	)
Amortization of debt discount, related party			-			(12,977	)		(5,000	)		(27,242	)			(0)			(3,044	)		(0)			(5,000	)
Financing fees																0						(43,750	)		0
Interest expense			(2,661	)		(4,545	)		(4,857	)		(8,609	)			(1,625	)		(1,139	)		(4,014	)		(2,196	)
Interest expense, related party			-			(1,356	)		(76	)		(3,979	)			0			(46	)		0			(76	)
Gain on forgiveness of accounts payable																0			(1,956	)		0			0
Loss on settlement of debt			-			-			(186,954	)		-				(4	)		0			(536	)		(186,954	)
Total other (expense)			(105,886	)		(171,301	)		(412,522	)		(326,205	)			(1,266,560	)		(72,634	)		(1,462,259	)		(306,636	)

Net loss attributable:
Non-controlling interest																(2,037,053	)					(3,214,869	)		0
Common stockholders																(3,489,430	)					(6,759,529	)		0
Net loss		$	(334,443	)	$	(292,960	)	$	(1,854,864	)	$	(589,157	)		$	(5,526,486	)	$	(1,193,349	)	$	(9,974,398	)	$	(1,520,421	)

Net loss per common share - basic and diluted		$	(0.00	)	$	(0.00	)	$	(0.01	)	$	(0.01	)		$	(0.02	)	$	(0.01	)	$	(0.03	)	$	(0.01	)

Weighted average number of common shares outstanding - basic and diluted			234,451,953			69,584,149			176,685,459			69,584,149				352,796,331			234,451,953			328,392,903			176,685,459

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

~~The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.~~

XERIANT, INC.
XERIANT, INC. AND SUBSIDIARY								XERIANT, INC. AND SUBSIDIARY
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS	CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS							CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(UNAUDITED)
(Unaudited)								(Unaudited)
									For the six months ended
		For the nine months ended March 31, 2021			For the nine months ended March 31, 2020				December 31, 2021			December 31, 2020

Cash Flows from Operating Activities
Net Loss		$	(1,854,864	)	$	(589,157	)		$	(9,974,398	)	$	(1,520,421	)
Adjustments to reconcile net loss to net
cash used by operating activities:
Stock compensation			1,113,583			-
Amortization of debt discount			215,635			286,375
Amortization of debt discount, related party			5,000			27,242
Adjustments to reconcile net loss to net cash used by operating activities:
Depreciation and Amortization										83			0
Stock compensation expense										1,887,545			1,027,109
Stock issued for services										657,204			-
Financing fees										43,750			0
Loss on settlement of debt			186,954			-				0			186,954
Amortization of Debt Discount										1,413,959			112,410
Amortization of Debt Discount, Related Party										0			5,000
Changes in operating assets & liabilities
Operating lease right of use asset			93			9,830				19,899			247
Changes in operating assets & liabilities						-
Deposits						(12,546	)
Prepaid expenses			(62,458	)		-
Accounts payable and accrued expenses			25,880			41,725
Accrued expenses, related parties			-			(1,143	)
Lease liabilities										(20,498	)		0
Deposits and prepaids										(1,589	)		271
Accounts payable and accrued liabilities										(49,475	)		25,873
Accrued liability, related party										5,000			0
Accrued expenses										5,520			0
Net cash used by operating activities			(370,177	)		(237,674	)			(6,013,001	)		(162,557	)

Cash Flows from Investing Activities
Purchase of property and equipment										(4,990	)		0
Net cash used in financing activities										(4,990	)		0

Cash Flows from Financing Activities
Sale of common stock			1,548,000			-				2,078,500			51,000
Cash from exercise of warrants										128,550			0
Proceeds from convertible notes payable			289,850			339,950				4,958,950			92,300
Proceeds from convertible notes payable, related party			-			33,000
Net cash provided by financing activities			1,837,850			372,950				7,166,000			143,300

Increase in Cash			1,467,673			135,276				1,148,009			(19,257	)

Cash at beginning of period			38,893			3,029				962,540			38,893

Cash at end of period		$	1,506,566		$	138,305			$	2,110,549		$	19,636

Supplemental Cash Flow Information
Cash paid for interest		$	-		$	-			$	0		$	0
Cash paid for income taxes		$	-		$	-			$	0		$	0

Non-cash investing and financing activities:
Conversion of convertible notes payable and accrued interest		$	130,410		$	135,739			$	437,246		$	129,859
Warrants issued with convertible notes payable		$	117,892		$	-			$	2,777,081		$	42,795
Beneficial conversion feature arising from convertible notes payable		$	171,958		$	48,650			$	2,615,419		$	49,505

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

Xeriant, Inc. (“Xeriant” or the “Company”) is an aerospace company dedicated to the emerging aviation market called Advanced Air Mobility (AAM), the transition to eco-friendly, on demand flight, making air transportation more accessible and a ~~holding and operating company~~greater part of our daily lives. Xeriant is focused on ~~acquiring, developing~~the acquisition, development, and ~~commercializing revolutionary, eco-friendly~~proliferation of next generation hybrid-electric and fully electric aircraft with vertical takeoff and landing (eVTOL) capabilities, performance enhancing aerospace technologies and advanced materials, with applications in aerospace, including innovative aircraft concepts, namely those capable of vertical takeoff and landing (VTOL). The Company is pursuing an active role in the “third wave of aeronautics,” which includes the electrification of aerial transport, advancements in structural design, propulsion systems, materials, sensors, artificial intelligence (AI), batteries, high-speed connectivity, and the development and integration of specialized aircraft with greatly reduced logistical footprints as well as ~~the infrastructure needed to facilitate these aircraft.~~critical support infrastructure. Xeriant is located at the Research Park at Florida Atlantic University in Boca Raton, Florida adjacent to the Boca Raton Airport, and trades on OTC Markets under the stock symbol, XERI.

On April 16, 2019, ~~Xeriant~~the Company and the members of American Aviation Technologies, LLC (“AAT”) entered into a Share Exchange Agreement ~~with American Aviation Technologies, LLC~~ (“~~AAT”~~Agreement”)~~, an aircraft design and development company focused~~. The Agreement, which became effective on ~~the emerging segment of the aviation industry of autonomous and semi-autonomous vertical take-off and landing (VTOL) unmanned aerial vehicles (UAVs).~~

On September 30, 2019, was pursuant to which the ~~acquisition~~Company acquired 100% of ~~AAT closed~~the issued and outstanding membership units in exchange for the issuance of shares of the Company’s Series A Preferred Stock constituting 86.39% of the total voting power of the Company’s capital stock to be outstanding upon closing, after giving effect to the consummation of concurrent debt settlement and other capital stock issuances but before the issuance of shares of capital stock for investor relations purposes. As a result of the Exchange Agreement, AAT became a wholly owned subsidiary of ~~Xeriant.~~ the Company.

On June 22, 2020, the name of the Company was changed to Xeriant, Inc. in the State of Nevada and subsequently approved by FINRA effective July 30, 2020 for the name and symbol ~~change.~~ change (XERI).

On May 27, 2021, the Company entered into a Joint Venture Agreement with XTI Aircraft Company, to form a new company, called Eco-Aero, LLC, for purpose of completing the preliminary design of XTI’s TriFan 600, a 5-passenger plus pilot, hybrid electric, vertical takeoff and landing (eVTOL) fixed wing aircraft.

The unaudited condensed consolidated financial statements of the Company and the accompanying notes included in this Quarterly Report are unaudited. In the opinion of management, all adjustments necessary for a fair presentation of the unaudited consolidated condensed financial statements have been included. Such adjustments are of a normal, recurring nature. The unaudited condensed consolidated financial statements, and the accompanying notes, are prepared in accordance with generally accepted accounting principles in the United States ~~("GAAP"~~(“GAAP”). Results for the interim periods presented are not necessarily indicative of the results that might be expected for the entire fiscal year. These financial statements should be read in conjunction with the company’s latest annual financial statements.

The condensed consolidated unaudited financial statements include the accounts of Xeriant, Inc. ~~and its wholly owned subsidiary~~, American Aviation Technologies, LLC, ~~collectively referred to as the Company.~~and Eco-Aero, LLC. All material intercompany accounts, transactions and profits were eliminated in consolidation. These financial statements should be read in conjunction with the company’s latest annual financial statements.

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The most significant assumptions and estimates relate to the valuation of beneficial conversion features and warrants associated with convertible debt. Actual results could differ from these estimates.

The Company adopted ASC Topic 820, Fair Value Measurements. ASC Topic 820 clarifies the definition of fair value, prescribes methods for measuring fair value, and establishes a fair value hierarchy to classify the inputs used in measuring fair value as follows:

Level 1: Inputs are unadjusted quoted prices in active markets for identical assets or liabilities available at the measurement date.

Level 2: Inputs are unadjusted quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets and liabilities in markets that are not active, inputs other than quoted prices that are observable, and inputs derived from or corroborated by observable market data.

Level 3: Inputs are unobservable inputs which reflect the reporting ~~entity's~~entity’s own assumptions on what assumptions the market participants would use in pricing the asset or liability based on the best available information.

The estimated fair value of certain financial instruments, including all current liabilities are carried at historical cost basis, which approximates their fair values because of the short-term nature of these instruments.

The Company follows Accounting Standards Codification subtopic 740-10, Income Taxes ("(“ASC ~~740-10"~~740-10”) for recording the provision for income taxes. Deferred tax assets and liabilities are computed based upon the difference between the financial statement and income tax basis of assets and liabilities using the enacted marginal tax rate applicable when the related asset or liability is expected to be realized or settled. Deferred income tax expenses or benefits are based on the changes in the asset or liability during each period. If available evidence suggests that it is more likely than not that some portion or all of the deferred tax assets will not be realized, a valuation allowance is required to reduce the deferred tax assets to the amount that is more likely than not to be realized. Future changes in such valuation allowance are included in the provision for deferred income taxes in the period of change. Deferred income taxes may arise from temporary differences resulting from income and expense items reported for financial accounting and tax purposes in different periods.

Deferred taxes are classified as current or non-current, depending on the classification of assets and liabilities to which they relate. Deferred taxes arising from temporary differences that are not related to an asset or liability are classified as current or non-current depending on the periods in which the temporary differences are expected to reverse and are considered immaterial. As of ~~March~~December 31, 2021 and June 30, ~~2020,~~2021 there are no deferred tax assets.

For purposes of the Statements of Cash Flows, the Company considers highly liquid investments with an original maturity of three months or less to be cash equivalents. The Company has no cash equivalents.

The Company monitors outstanding receivables based on factors surrounding the credit risk of specific customers, historical trends, and other information. The allowance for doubtful accounts is estimated based on an assessment of the ~~Company's~~Company’s ability to collect on customer accounts receivable. There is judgment involved with estimating the allowance for doubtful accounts and if the financial condition of the ~~Company's~~Company’s customers were to deteriorate, resulting in their inability to make the required payments, the Company may be required to record additional allowances or charges against revenues. The Company writes-off accounts receivable against the allowance when it determines a balance is uncollectible and no longer actively pursues its collection. The allowance for doubtful accounts is created by forming a credit balance which is deducted from the total receivables balance in the balance sheet. As of ~~March~~December 31, 2021 and June 30, ~~2020~~2021 there are no accounts receivable.

Revenue includes product sales. The Company recognizes revenue from product sales in accordance with Topic 606 ~~"Revenue~~“Revenue Recognition in Financial ~~Statements"~~Statements” which considers revenue realized or realizable and earned when all of the following criteria are met:

For the ~~nine~~six months ended ~~March~~December 31, 2021 and 2020, the Company ~~had~~has no revenue.

If the conversion features of conventional convertible debt provide for a rate of conversion that is below market value at issuance, this feature is characterized as a beneficial conversion feature ~~("BCF"~~(“BCF”). A BCF is recorded by the Company as a debt discount pursuant to ASC Topic 470-20 ~~"Debt~~“Debt with Conversion and Other Options."” In those circumstances, the convertible debt is recorded net of the discount related to the BCF, and the Company amortizes the discount to interest expense, over the life of the debt. During the ~~nine~~six months ended ~~March~~December 31, 2021, the Company recorded a BCF in the amount of ~~$171,958.~~$2,365,419.

Accounting Standards Codification subtopic 825-10, Financial Instruments ("(“ASC ~~825-10"~~825-10”) requires disclosure of the fair value of certain financial instruments. The carrying value of cash, accounts payable and accrued liabilities as reflected in the balance sheets, approximate fair value because of the short-term maturity of these instruments. All other significant financial assets, financial liabilities and equity instruments of the Company are either recognized or disclosed in the financial statements together with other information relevant for making a reasonable assessment of future cash flows, interest rate risk and credit risk. Where practicable the fair values of financial assets and financial liabilities have been determined and disclosed; otherwise only available information pertinent to fair value has been disclosed.

The Company follows Accounting Standards Codification subtopic 820-10, Fair Value Measurements and Disclosures ("(“ASC ~~820-10"~~820-10”) and Accounting Standards Codification subtopic 825-10, Financial Instruments ("(“ASC ~~825-10"~~825-10”), which permits entities to choose to measure many financial instruments and certain other items at fair value.

Expenditures for research and development are expensed as incurred. The Company incurred research and development expenses of $0$5,200,219 and ~~$6,339~~$0 for the ~~nine~~six months ended ~~March~~December 31, 2021 and 2020, respectively.

The Company expenses advertising and marketing costs as they are incurred. ~~There were no~~The Company recorded advertising ~~costs during~~expenses in the ~~nine~~amount of $164,713 and $0 for the six months ended ~~March~~December 31, 2021 and ~~2020.~~2020, respectively. These expenses are included within sales in marketing expenses in the statements of operations.

Costs incurred in connection with raising capital by the issuance of common stock are recorded as contra equity and deducted from the capital raised. There were no offering costs ~~during~~for the ~~nine~~six months ended ~~March~~December 31, 2021 and ~~2020.~~2020, respectively.

The Company recognizes the effect of income tax positions only if those positions are more likely than not of being sustained. Recognized income tax positions are measured at the largest amount that is greater than 50% likely of being realized. Changes in recognition or measurement are reflected in the period in which the change in judgment occurs. The Company records interest and penalties related to unrecognized tax benefits as a component of general and administrative expenses. Our consolidated federal tax return and any state tax returns are not currently under examination.

The Company has adopted FASB ASC 740-10, Accounting for Income Taxes, which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed annually from differences between the financial statement and tax basis of assets and liabilities that will result in taxable or deductible amounts in the future based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized.

~~In May 2014, the FASB issued ASU 2014-09,~~ ~~Revenue from Contracts with Customers~~, issued as a new Topic, ASC Topic 606. The new revenue recognition standard supersedes all existing revenue recognition guidance. Under this ASU, an entity should recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. ASU 2015-14, issued in August 2015, deferred the effective date of ASU 2014-09 to the first quarter of 2018, with early adoption permitted in the first quarter of 2017.

In February 2016, FASB issued ASC 842 that requires lessees to recognize lease assets and corresponding lease liabilities on the balance sheet for all leases with terms of more than 12 months. The update, which supersedes existing lease guidance, will continue to classify leases as either finance or operating, with the classification determining the pattern of expense recognition in the income statement.

The ASU will be effective for annual and interim periods beginning after December 15, 2019, with early adoption permitted, and is applicable on a modified retrospective basis with various optional practical expedients. The Company has assessed the impact of this standard. The Company entered into a new lease agreement commencing on November 1, 2019 and implemented this guidance on November 1, 2019.

In August ~~2016,~~2020, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) ~~No. 2016-15, Statement~~2020-06, Debt — Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging — Contracts in Entity’s Own Equity (Subtopic 815-40) (“ASU 2020-06”) to simplify accounting for certain financial instruments. ASU 2020-06 eliminates the current models that require separation of ~~Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments. This update addresses a diversity in practice in how certain cash receipts~~beneficial conversion and cash ~~payments are presented~~conversion features from convertible instruments and ~~classified in~~simplifies the ~~statement~~derivative scope exception guidance pertaining to equity classification of cash flows under Topic 230, Statement of Cash Flows, and other Topics. The amendments in this Update are effective for public business entities for fiscal years beginning after December 15, 2017, and interim periods within those fiscal years. Early adoption is permitted, including adoptioncontracts in an ~~interim period.~~

~~On June 20, 2018, the FASB issued ASU 2018-07,~~ ~~Compensation—Stock Compensation~~ (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting. ASU 2018-07 is intended to reduce cost and complexity and to improve financial reporting for share-based payments to nonemployees (for example, service providers, external legal counsel, suppliers, etc.). Under theentity’s own equity. The new standard ~~companies will no longer~~also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity’s own equity. ASU 2020-06 amends the diluted earnings per share guidance, including the requirement to use the if-converted method for all convertible instruments. ASU 2020-06 is effective January 1, 2024 and should be required to value non-employee awards differently from employee awards. Meaning that companies will value all equity classified awards at their grant-date under ASC 718 and forgo revaluing the award after this date. The Company adopted ASU 2018-07applied on ~~August 6, 2018.~~a full or modified retrospective basis, with early adoption permitted beginning on January 1, 2021. The adoption of ~~this standard did not~~ASU 2020-06 is expect to have a material impact on the Company’s financial statements.

The Company has implemented all new accounting pronouncements that are in effect. These pronouncements did not have any material impact on the consolidated financial statements unless otherwise disclosed, and the Company does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its financial position or results of operations.

On ~~January 8,~~May 31, 2021, the Company entered into a ~~binding memorandum~~Joint Venture Agreement (the “Agreement”) with XTI Aircraft Company (“XTI”), a Delaware corporation, to form a new company, called Eco-Aero, LLC (the “JV”), a Delaware limited liability company, with the purpose of ~~understanding~~completing the preliminary design of XTI’s TriFan 600, a 5-passenger plus pilot, hybrid electric, vertical takeoff, and landing (eVTOL) fixed wing aircraft. Under the Agreement, Xeriant is contributing capital, technology, and strategic business relationships, and XTI is contributing intellectual property licensing rights and know-how. XTI and the Company each own 50 percent of the JV. The JV is managed by a management committee consisting of five members, three appointed by the Company and two by XTI. The Agreement was effective on June 4, 2021, with ~~Xeriant Europe s.r.o. for~~an initial deposit of $1 million into the JV. Xeriant’s financial commitment is $10 million, contributed over a ~~joint venture (“JV”).~~ period of less than one year, as required by the aircraft development timeline and budget.

The Company ~~paid a total of $62,000 in deposits~~analyzed the transaction under ASC 810 Consolidation, to Xeriant Europe in February and March of 2021 for patent related fees. The purpose of the JV with Xeriant Europe is to generate revenue by sourcing and accelerating breakthrough technologies, primarily from Central Europe, that can be commercialized and introduced to new markets, such as the United States. As of March 31, 2021,determine if the joint venture classifies as a Variable Interest Entity (“VIE”). The Joint Venture qualifies as a VIE based on the fact the JV does not have sufficient equity to operate without financial support from Xeriant. According to ASC 810-25-38, a reporting entity shall consolidate a VIE when that reporting entity has a variable interest (or combination of variable interests) that provides the reporting entity with a controlling financial interest on the basis of the provisions in paragraphs 810-10-25-38A through 25-38J. The reporting entity that consolidates a VIE is called the primary beneficiary of that VIE. According to the JV operating agreement, ~~had not been finalized.~~the ownership interests are 50/50. However, the agreement provides for a Management Committee of five members. Three of the five members are from Xeriant. Additionally, Xeriant has an obligation to invest $10,000,000 into the JV. As such, Xeriant has substantial capital at risk. Based on these two factors, the conclusion is that Xeriant is the primary beneficiary of the VIE. Accordingly, Xeriant has consolidated the VIE.

The Company maintains accounts with financial institutions. All cash in checking accounts is non-interest bearing and is fully insured by the Federal Deposit Insurance Corporation (FDIC). At times, cash balances may exceed the maximum coverage provided by the FDIC on insured depositor accounts. The Company believes it mitigates its risk by depositing its cash and cash equivalents with major financial institutions. ~~At March~~On December 31, 2021, the Company had ~~$1,256,566~~$1,855,883 in excess of FDIC insurance.

NOTE 5 –- OPERATING LEASE RIGHT-OF-USE ASSET AND OPERATING LEASE LIABILITY

The Company leases 2,911 square feet of office space located in the Research Park at Florida Atlantic University, Innovation Centre 1, 3998 FAU Boulevard, Suite 309, Boca Raton, Florida. The Company entered into a lease agreement commencing on November 1, 2019 through January 1, 2025 in which the first three months of rent were abated. Due to the COVID-19 pandemic, the Company decided to have all employees work from home and intends to build out the office space by the end of 2021 to allow employees to work from the office in 2022 as COVID-19 cases went up significantly in the first quarter of 2022. The following table illustrates the base rent amounts over the term of the lease:

Operating lease right-of-use asset and liability are recognized at the present value of the future lease payments at the lease commencement date. The interest rate used to determine the present value is our incremental borrowing rate, estimated to be 10%, as the interest rate implicit in most of our leases is not readily determinable. Operating lease expense is recognized on a straight-line basis over the lease term. Since the common area maintenance expenses are expenses that do not depend on an index or rate, they are excluded from the measurement of the lease liability and recognized in other general and administrative expenses on the statements of operations. At inception the Company paid prepaid rent in the amount of $4,659, which was netted against the operating lease right-of-use asset balance until it was applied in February 2020.

				December 31,
	March 31, 2021			2021
Office lease	$	220,448		$	220,448
Less: accumulated amortization		(41,662	)		(71,138	)
Right-of-use asset, net	$	178,786		$	149,310

On April 16, 2019, Xeriant, Inc., and the members of American Aviation Technologies, LLC (“AAT”) entered into a Share Exchange Agreement (“Agreement”). The agreement, which became effective on September 30, 2019, was pursuant to which the Company acquired 100% of the issued and outstanding membership units in exchange for the issuance of shares of the Company’s Series A Preferred Stock constituting 86.39% of the total voting power of the Company’s capital stock to be outstanding upon closing, after giving effect to the consummation of concurrent debt settlement and other capital stock issuances but before the issuance of shares of capital stock for investor relations purposes. As a result of the Exchange Agreement, AAT became a wholly owned subsidiary of the Company.

~~On September 30, 2019 just prior to the exchange, Xeriant issued 170,000 shares of preferred stock as compensation and 193,637 shares of preferred stock in satisfaction of $2,608,224 in liabilities.~~

The carrying ~~values~~value of convertible notes payable, net of discount, as of ~~March~~December 31, 2021 and June 30, ~~2020~~2021 was ~~$102,920~~$721,055 and ~~$32,734,~~$158,196, respectively, as summarized ~~below.~~below:

The following table illustrates the carrying values for the convertible notes payable as of December 31, 2021 and June 30, 2021:

Between September 27, 2019 and ~~July 20, 2020, AAT~~August 10, 2021, the Company issued convertible notes payable with an aggregate face value of ~~$357,750 with~~$892,300, of which $342,950 were issued by our subsidiary AAT. The notes have a coupon rate of 6%~~. The notes have a~~ and maturity ~~date of~~dates between three and six months. The agreements provided ~~that in the event AAT is merged into Xeriant (the “Company”), at any time prior to the Maturity Date,~~ the holder has the option to convert the principal balance and any accrued interest to common stock of the ~~Company at a conversion price of $.0033 per share.~~Company. In the event the holder does not elect to convert the note prior to maturity, the note will automatically convert to common ~~stock~~stock. Of the $892,300, $342,950 is convertible at ~~a price of~~ $.0033 per ~~share.~~share, $87,000 is convertible at $0.025 per share, $180,550 is convertible at $.03 per share, $31,800 is convertible at $0.003 per share, and the remaining $250,000 is convertible at $.06 per share

Between March 27, 2020 and July 11, 2021, holders of the convertible notes converted the $342,950 in principal (the full balance of the AAT Notes) and $10,290 in accrued interest into 107,042,708 shares of common stock. Between November 10, 2020 and July 11, 2021, holders of the convertible notes converted $299,350 in principal and $7,224 in accrued interest into 19,641,327 shares of common stock. During the six months ended December 31, 2021, holders of the convertible notes converted $417,550 in principal and $5,520 in accrued interest into 10,598,544 shares of common stock. The remaining principal balance of the notes as of December 31, 2021 was $0. The Company have not issued the stock for the conversion of $100,000 convertible notes payable issued on August 9, 2021 and $150,000 convertible notes payable issued on August 10, 2021 and recorded under common stock to be issued as of December 31, 2021.

The Company evaluated ~~the agreement~~these notes under ASC 815 Derivatives and Hedging (“ASC 815”). ASC 815 generally requires the analysis embedded terms and features that have characteristics of derivatives to be evaluated for bifurcation and separate accounting in instances where their economic risks and characteristics are not clearly and closely related to the risks of the host contract. None of the embedded terms required bifurcation and liability classification. However, the Company was required to determine if the debt contained a beneficial conversion feature (“BCF”), which is based on the intrinsic value on the date of issuance. ~~The Company recorded a beneficial conversion feature in the amount of $357,750 related to these notes.~~

~~Between March 27, 2020 and November 10, 2020, holders of the convertible notes converted $344,450 in principal and $10,336 in accrued interest into 107,510,927 shares of common stock.~~

Between August 10, 2020 and January 19, 2021, the Company issued convertible notes payable with an aggregate face value of $284,550 with a coupon rate of 6%. The notes have a maturity date of three and six months. The agreements provided the holder has the option to convert the principal balance and any accrued interest to common stock of the Company. In the event the holder does not elect to convert the note prior to maturity, the note will automatically convert to common stock. Of the $284,550, $87,000 is convertible at $0.025 per share, $180,550 is convertible at $.03 per share, and the remaining $17,000 is convertible at $0.003 per share.

The Company evaluated the agreement under ASC 815 Derivatives and Hedging (“ASC 815”). ASC 815 generally requires the analysis embedded terms and features that have characteristics of derivatives to be evaluated for bifurcation and separate accounting in instances where their economic risks and characteristics are not clearly and closely related to the risks of the host contract. None of the embedded terms required bifurcation and liability classification.

In connection with the notes, the Company issued warrants ~~indexed~~ to purchase an aggregate ~~8,498,333~~8,848,333 shares of common stock. The warrants have a term of two years and an exercise price of $.025. The Company evaluated the warrants under ASC 815 Derivatives and Hedging (“ASC 815”) and determined that they did not require liability classification. The warrants were recorded in additional paid-in capital under their aggregate relative fair value of $156,225.

The Company was required to determine if the debt contained a beneficial conversion feature (“BCF”), which is based on the intrinsic value on the date of issuance. After the allocation of $156,225 to the warrants, the remaining ~~$169,956~~$512,906 in proceeds resulted in a beneficial conversion feature recorded in additional paid-in capital. Both the BCF and warrants resulted in a debt discount and are amortized over the life of the note.

For the ~~nine~~six months ended ~~March~~December 31, 2021 and 2020, the Company recorded ~~$220,636~~$1,413,959 and ~~$285,804~~$112,410 in amortization of debt discount related to the notes. For the ~~nine~~six months ended ~~March~~December 31, 2021 and 2020, the Company recorded ~~$4,933~~$4,014 and ~~$3,979~~$2,196 in interest expense related to the notes, respectively.

On October 27, 2021, the Company issued a convertible note payable with Auctus Fund, LLC (the “Auctus Note”) with the principal sum of $6,050,000, which amount is the $5,142,500 actual amount of the purchase price, hereof plus an original issue discount in the amount of $907,500 and to pay interest on the unpaid principal amount hereof at the rate of zero percent per annum from the issue date until the note becomes due and payable, and $433,550 for professional fees in completing the transactions, so the net proceeds from the Auctus Fund LLC was $4,708,950. The note has a maturity date of twelve months. The agreement provides the holder has the option to convert the principal balance and any accrued interest to common stock of the Company at a conversion price of lesser of (i) $0.1187 or (ii) 75% of the offering price per share divided by the number of shares of common stock.

In connection with the notes, the Company issued warrants indexed to an aggregate 50,968,828 shares of common stock. The warrants have a term of five years and an exercise price of $0.1187. The warrants were recorded at fair value of $2,777,081 to additional-paid-in-capital in accordance with ASC 815-10 based upon the allocation of the debt proceeds. The Company estimated the fair value of the warrants using a Black-Scholes option-pricing model, which is based, in part, upon subjective assumptions including but not limited to stock price volatility, the expected life of the warrants, the risk-free interest rate and the fair value of the common stock underlying the warrants. The Company estimates the volatility of its stock based on the average of three similar size public companies peer group historical volatility that is in line with the expected remaining life of the warrants. The risk-free interest rate is based on the U.S. Treasury zero-coupon bond for a maturity similar to the expected remaining life of the warrants. The expected remaining life of the warrants is assumed to be equivalent to their remaining contractual term.

The Company was required to determine if the debt contained a beneficial conversion feature (“BCF”), which is based on the intrinsic value on the date of issuance. The Company recorded $2,365,419 conversion feature in additional paid-in capital. The BCF resulted in a debt discount and are amortized over the life of the note.

For the six months ended December 31, 2021, the Company recorded $1,154,605 amortization of debt discount related to the Auctus note.

During the nine months ended March 31, 2021, the Company paid Ancient Investments, LLC, a Company owned by the Company’s CEO, Keith Duffy and the Company’s Executive Director of Corporate Operations, Scott Duffy, $66,000 for consulting services.

During the nine months ended March 31, 2021, the Company paid AMP Web Services, a Company owned by the Company’s CTO, Pablo Lavigna, $32,500 for consulting services. On August 26, 2020, the Company issued 4,090,909 shares of common stock for payment of $13,500 for services performed in May, June and July 2020. As of March 31, 2021, $4,500 is due for March services and recorded in accrued liabilities, as a related party.

During the nine months ended March 31, 2021, the Company owed $22,500 to Keystone Business Development Partners, a Company owned by the Company’s CFO, Brian Carey. Of the amount owed, $22,500 is recorded in accrued liabilities, related party and the remaining $7,500 is recorded in accounts payable.

On August 25, 2020, the Company issued a convertible note payable with a face value of $5,000 with a coupon rate of 6% to Keystone Business Development Partners, a Company owned by the Company’s CFO, Brian Carey. The note has a maturity date of three months. The agreement provides the holder has the option to convert the principal balance and any accrued interest to common stock of the Company at a conversion price of $.025 per share. In the event the holder does not elect to convert the note prior to maturity, the note will automatically convert to common stock at a price of $.025 per share. ~~The note was converted into 203,025 common shares on November 25, 2020, which were issued on February 8, 2021.~~

In connection with the note, the Company issued warrants indexed to an aggregate 200,000 shares of common stock. The warrants have a term of two years and an exercise price of $.025. The Company evaluated the warrants under ASC 815 Derivatives and Hedging (“ASC 815”) and determined that they did not require liability classification. The warrants were recorded in additional paid-in capital under their relative fair value of $2,461.

The Company was required to determine if the debt contained a beneficial conversion feature (“BCF”), which is based on the intrinsic value on the date of issuance. After the allocation of $2,461 to the warrants, the remaining $2,539 in proceeds resulted in a beneficial conversion feature recorded in additional paid-in capital. Both the BCF and warrants resulted in a debt discount and are amortized over the life of the note.

For the ~~nine~~six months ended ~~March~~December 31, 2021 and 2020, the Company recorded $0 and $5,000 in amortization of debt discount related to the note. For the ~~nine~~six months ended ~~March~~December 31, 2021 and 2020, the Company recorded $0 and $76 in interest expense related to the ~~note.~~note, respectively.

On November 25, 2020, Keystone Business Development Partners converted $5,000 in principal and $76 in accrued interest into 203,024 shares of common stock.

During the three months ended December 31, 2021 and 2020, the Company recorded $41,000 and $36,000 respectively, in consulting fees to Ancient Investments, LLC, a Company owned by the Company’s CEO, Keith Duffy and the Company’s Executive Director of Corporate Operations, Scott Duffy.

For the three months ended December 31, 2021 and 2020, the Company recorded $28,000 and $0 respectively, in consulting fees to Edward DeFeudis, a Director of the Company.

During the three months ended December 31, 2021 and 2020, the Company recorded $19,000 and $22,500 respectively, in consulting fees to AMP Web Services, a Company owned by the Company’s CTO, Pablo Lavigna.

During the three months ended December 31, 2021 and 2020, the Company recorded $7,500 and $15,000 respectively, in consulting fees to Keystone Business Development Partners, a Company owned by the Company’s CFO, Brian Carey. As of December 31, 2021 and June 30, 2021, $30,000 and $25,000 was recorded in accrued liabilities related to Keystone Business Development Partners, respectively.

During the normal course of business, the Company may be exposed to litigation. When the Company becomes aware of potential litigation, it evaluates the merits of the case in accordance with FASB ASC 450-20-50, Contingencies. The Company evaluates its exposure to the matter, possible legal or settlement strategies and the likelihood of an unfavorable outcome. If the Company determines that an unfavorable outcome is probable and can be reasonably estimated, it establishes the necessary accruals. ~~As of March~~

In connection with the Eco-Aero, LLC Joint Venture, discussed in Note 3, the Company is obligated to invest $10,000,000 into the joint venture.

On August 10, 2021, the Company entered into an Advisory Agreement with a firm to assist the Company with fundraising activities. In connection with the agreement, the Company has the following commitments:

During the three and six months ended December 31, 2021, the Company ~~is not aware~~issued the initial 500,000 shares and second tranche of ~~any contingent liabilities that should be reflected~~500,000 shares.

On August 19, 2021, the Company entered into an Advisory Agreement with a firm to assist the Company with fundraising activities. In connection with the agreement, the Company has the following commitments:

During the six months ended December 31, 2021, the Company issued the initial 2,225,000 shares.

On September 1, 2021, Xeriant Inc. brought a cause of action in the ~~financial statements.~~Southern District of Florida against a former shareholder for claims, including but not limited to, breach of contract, misrepresentation, and asserting claims to recoup monetary and in-kind distributions made to the shareholder by the Company. The defendant submitted an affirmative defense and counterclaim on October 29, 2021.

The Company has entered into advisor agreements with various advisory board members. The agreements provide for the following:

On October 27, 2020, the Company agreed to issue 300,000 common shares immediately, 2-year cashless warrants to purchase 300,000 common shares at the current price, and $2,500 per meeting paid 50% in cash and 50% in common shares.

On January 18, 2021, the Company agreed to issue 50,000 common shares, two-year cashless warrants to purchase 25,000 common shares at the current price, and $2,500 per meeting paid in cash, common shares, or a combination.

On January 22, 2021, the Company agreed to issue 50,000 common shares, two-year cashless warrants to purchase 25,000 common shares at the current price, and $2,500 per meeting paid in cash, common shares, or a combination.

On March 7, 2021 the Company paid an advisor $2,500 and issued 50,000 common shares.

On July 1, 2021, the Company agreed to issue 100,000 common shares, and $2,500 per meeting paid in cash, common shares, or a combination, an additional bonus of $25,000 paid in common shares issued at the end of each year of service, an option to purchase 5,000,000 common shares at $0.12 per share, vesting quarterly over 24 months, and for each of the following three years (beginning July 1, 2022), an option to purchase an additional 1,000,000 common shares per year thereafter at a 25% discount to the average market price for the preceding 10 trading days.

On July 6, 2021, provided an option to purchase 5,000,000 common shares at $0.12 per share, vesting quarterly over 24 months, a bonus of 250,000 common shares issued upon a strategic partnership with a major airline, $2,500 per formal meeting paid in common shares, and an additional bonus of $25,000 paid in common shares issued at the end of each year of service.

On July 28, 2021, the Company agreed to issue 250,000 common shares immediately, an option to purchase 5,000,000 common shares at $0.12 per share, vesting quarterly over 24 months, a bonus of 5,000,000 common shares for bringing in a strategic partner that significantly strengthens the Company’s market position, $2,500 per formal meeting paid in cash, common shares or a combination, and an additional bonus of $25,000 paid in common shares issued at the end of each year of service

On August 9, 2021, the Company agreed to issue 50,000 common shares, $2,500 per meeting paid in cash, common shares, or a combination, and an additional bonus of $25,000 paid in common shares issued at the end of each year of service.

On August 20, 2021, the Company agreed to issue 100,000 common shares, and $2,500 per meeting paid in cash, common shares, or a combination, an additional bonus of $25,000 paid in common shares issued at the end of each year of service, an option to purchase 4,000,000 common shares at $0.12 per share, vesting quarterly over 24 months.

The Company has announced its intention to enter into certain joint ventures and partnerships over the past 12 months, namely Praga Avia, CoFlow Jet, and TheIncLab. Due to the Company’s focus on its joint development with XTI Aircraft Company, the advancement of these partnerships has been put on hold. The Company anticipates revisiting these opportunities after the completion of a public offering when the Company is fully staffed and adequately financed. The Company signed a term sheet in January 2022 with Movychem s.r.o. for a joint venture. Both parties expect to sign a final definite agreement in February 2022.

During the ~~nine~~three months ended ~~March 31,~~September 30, 2021, the Company issued ~~112,847,466~~400,000 shares of common stock related to a subscription agreement from the previous fiscal year, which were previously recorded in common stock to be issued at $48,000.

During the three months ended September 30, 2021, the Company sold 7,500,000 shares of common stock for aggregate proceeds of $500,000, or $0.10per share.

In connection with one of the subscription agreements, the Company issued 250,000 shares as an equity kicker valued at $43,750, which has been expensed as a financing costs.

During the three months ended September 30, 2021, the Company issued 4,185,000 shares of common stock as a result of warrant exercises in the aggregate proceeds of $125,550.

During the three months ended September 30, 2021, the Company issued 4,000,000 shares of common stock in exchange for the conversion of 4,000 shares of Series A Preferred Stock.

During the three months ended September 30, 2021, the Company issued 10,598,544 shares of common stock for the conversion of ~~$359,300~~$167,550 in principal and ~~$13,097~~$4,985 in accrued interest. This resulted in a loss on extinguishment of debt in the amount of $535.

During the ~~nine~~three months ended ~~March~~September 30, 2021, the Company issued 2,825,000 shares of common stock for services, valued at $449,200.

During the three months ended December 31, 2021, the Company sold 8,200,000 shares of common stock for aggregate proceeds of $410,000, or $0.05 per share.

During the three months ended December 31, 2021, the Company issued ~~24,153,385~~23,266,666 shares of common stock for aggregate proceeds of $1,162,500, or $0.05 per share for the sale of common shares that has not been issued in the quarter ended September 30, 2021.

During the three months ended December 31, 2021, the Company issued 123,600 shares of common stock for the ~~conversion~~$3,000 exercise of ~~$150,450~~warrants in ~~principal and $3,260 in accrued interest.~~the quarter ended September 30, 2021.

~~On August 26, 2020,~~During the three months ended December 31, 2021, the Company issued ~~4,090,909~~3,138,000 shares of common stock in exchange for the conversion of 3,318 shares of Series A Preferred Stock.

During the three months ended December 31, 2021, the Company issued 900,000 shares of common stock for ~~payment of $13,500 for~~ services, ~~performed in May, June and July 2020. The shares were~~ valued at ~~$200,454 or $0.049 per share. As of result the Company recorded a loss on settlement in debt in the amount of $186,954.~~$116,105.

During the ~~nine~~three months ended ~~March 31,~~September 30, 2021, ~~certain holders of preferred stock converted 39,358 shares into 39,358,000 shares of common stock.~~

~~On October 30, 2020, the Company issued 300,000 shares of common stock to an advisory board member for services. The shares were valued at $13,200 or $0.044 per share.~~

~~On November 17, 2020,~~ the Company sold ~~1,700,000 shares of common for $25,500, or $0.015 per share.~~

~~On November 24, 2020, the Company sold 1,700,000 shares of common for $25,500, or $0.015 per share.~~

~~On December 1, 2020, the Company issued 2,000,000~~200,000 shares of common stock for ~~investment relation services valued at $100,000,~~aggregate proceeds of $6,000, or ~~$0.05~~$0.03 per share. As of December 31, 2021, these shares are categorized in common stock to be issued.

~~On December 1, 2020,~~During the ~~Company issued 18,000,000 shares of common stock for investment relation services valued at $900,000, or $0.05 per share.~~

~~On January 29,~~three months ended September 30, 2021, the Company ~~issued 50,000~~agreed to pay a consultant 250,000 shares in exchange to $45,500 in services. As of December 31, 2021, these shares are categorized in common stock to ~~an advisory board member for services. The shares were valued at $25,500 or $0.51 per share.~~be issued.

~~On March 22,~~During the three months ended September 30, 2021, the Company ~~issued~~agreed to issue advisory board members 250,000 shares in exchange for $46,400 in services. 200,000 shares vest on a quarterly basis over one year and 50,000 shares vest completely after a year. As of December 31, 2021, these shares are categorized in common stock to ~~an advisory board member for services. The shares were valued at $13,800 or $0.28 per share.~~be issued.

~~On March 22,~~During the three months ended December 31, 2021, the Company ~~issued 50,000 shares~~received conversion of ~~common stock to an advisory board member for services. The shares were valued at $22,750 or $0.46 per share.~~

~~On March 22, 2021, the Company issued 9,991,667 shares for $1,199,000, or $0.12 per share.~~convertible notes payable of total $250,000.

There are 100,000,000 shares authorized as preferred stock, of which 3,500,000 are designated as Series A Preferred Stock having a par value of $0.00001 per share. The Series A preferred stock has the following rights:

~~During the nine months ended March 31, 2021, certain holders of preferred stock converted 39,358 shares into 39,358,000 shares of common stock.~~

As of ~~March~~December 31, 2021 and June 30, ~~2020,~~2021, the Company has ~~793,279~~781,132 and ~~3,113,638~~788,270 shares of Series A Preferred Stock issued and outstanding, respectively.

On February 15, 2021, in accordance with Florida Law and conversations with counsel, the Board of Directors of the Company rescinded 990,000 Series A Preferred Shares, which represented all preferred shares issued to ~~key man, Russell Randall,~~one of the shareholders in the Share Exchange between American Aviation Technologies, LLC and Xeriant, Inc. entered into on April 19, 2019, due to breach of contract.

During March of 2021, the remaining former members of American Aviation Technologies, LLC agreed to allow the Company to rescind an aggregate of 1,250,001 of their 1,760,000 Series A Preferred Shares issued pursuant to the Share Exchange between American Aviation Technologies, LLC and Xeriant, Inc., as a result of said breach. As a result of the cancellation, the Company reduced the investment in AAT by the value of these preferred shares.

During the six months ended December 31, 2021, the Company issued 3,138,000 shares of common stock in exchange for the conversion of 3,138 shares of Series A Preferred Stock.

On March 25, 2021, the Certificate of Designation for the Series B Preferred was recorded by the State of Nevada. There are 100,000,000 shares authorized as preferred stock, of which 1,000,000 are designated as Series B Preferred Stock having a par value of $0.00001 per share. The Series B preferred stock is not convertible, does not have any voting rights and no liquidation preference.

In connection with certain advisory board compensation agreements, the Company issued an aggregate 19,000,000 options at an exercise price of $0.12 per share. These options vest quarterly over twenty-four months and have a term of three years. The grant date fair value was $3,543,787. The Company recorded compensation expense in the amount of $1,887,545 for the six months ended December 31, 2021 for these options.

As of December 31, 2021, there are 19,000,000 options outstanding, of which 2,375,000 are exercisable. The weighted averaged remaining term is 2.55 years.

Significant inputs and results arising from the Black-Scholes process are as follows for the options:

As of December 31, 2021 and June 30, 2021, the Company had 55,512,161 and 8,848,333 warrants outstanding, respectively. The warrants were issued in connection with the Convertible Notes (See Note 6). The warrants have a term of two to five years and an exercise price range from $0.1187 to $.025. The Company evaluated the warrants under ASC 815 Derivatives and Hedging (“ASC 815”) and determined that they did not require liability classification. The warrants were recorded in additional paid-in capital under their aggregate relative fair value of $2,933,305. During the six months ended December 31, 2021, holders of warrants exercised warrants for 4,305,000 shares of common stock for aggregate proceeds of $128,550. As of December 31, 2021, the weighted average remaining useful life of the warrants was 1.08.

On ~~March 27,~~May 12, 2021, ~~Spider Investments,~~on further advice of counsel and in good faith, the Company returned 3,600,000 membership units of American Aviation Technologies, LLC ~~returned 41,000 Series A Preferred Shares~~ to a former shareholder, which was his consideration provided in the ~~treasury of~~Share Exchange between American Aviation Technologies, LLC and Xeriant, Inc. As a result, this former shareholder was restored to his original shareholding position in American Aviation Technologies, LLC.

On May 12, 2021, the ~~Company.~~Company’s position in American Aviation Technologies, LLC was reduced to 64%, and therefore the subsidiary is now classified as majority owned.

The ~~Company's~~Company’s financial statements are prepared using the generally accepted accounting principles applicable to a going concern, which contemplates the realization of assets and liquidation of liabilities in the normal course of business. ~~At March~~As of December 31, 2021 and June 30, ~~2020,~~2021, the Company had ~~$1,506,566~~$2,110,549 and ~~$38,893~~$962,540 in cash and ~~$1,393,092~~$1,305,399 and $677,257 in ~~working capital and $53,532 in negative~~ working capital, respectively. For the ~~nine~~six months ended ~~March~~December 31, 2021 and 2020, the Company had a net loss of ~~$1,854,864~~$9,974,398 and ~~$334,443,~~$1,520,421, respectively. Continued losses may adversely affect the liquidity of the Company in the future. Therefore, the factors noted above raise substantial doubt about our ability to continue as a going concern. The recoverability of a major portion of the recorded asset amounts shown in the accompanying balance sheets is dependent upon continued operations of the Company, which in turn is dependent upon the ~~Company's~~Company’s ability to raise additional capital, obtain financing and to succeed in its future operations. The financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern. The Company’s existence is dependent upon management’s ability to develop profitable operations and resolve its liquidity problems.

~~On April 1, 2021,~~In February 2022, the Company issued ~~2,083,334~~4,229,680 common shares ~~for $250,000, or $0.12 per share. The $250,000 proceeds were received in March 2021.~~

~~On April 26, 2021, the Company issued 1,014,798 shares of common stock~~ for the conversion of ~~$30,000 in principal~~convertible notes payable of total $250,000 and ~~$443 in accrued interest.~~additional 845,936 common shares as additional financing costs to these two convertible holders.

~~On May 12, 2021, on further advice of counsel and in good faith~~,In February 2022, the Company ~~returned 3,600,000 membership units~~issued 1,000,000 common shares from the conversion of American Aviation Technologies, LLC to Russell Randall, which was his consideration provided in the Share Exchange between American Aviation Technologies, LLC and Xeriant, Inc. As a result, Mr. Randall was restored to his original shareholding position in American Aviation Technologies, LLC.

~~On May 12, 2021, the Company’s position in American Aviation Technologies, LLC was reduced to 64%, and therefore the subsidiary is now classified as majority owned.~~

~~On April 3, 2021, the Company entered into a subscription agreement for the sale of 833,333 shares for $100,000 or $0.12 per share.~~

On May 5, 2021, Xeriant filed trademark applications with the U.S. Patent and Trademark Office under four services classes for each application, including the name “Xeriant,” the Xeriant Aerospace logo, and the tag line “Innovation Soaring.” On May 13, 2021, Xeriant filed trademark applications for the expressions “Evolution in Flight” and “Evolution of Flight” under the same classes for each application.

On May 12, 2021, the Company executed an employment agreement with Keith Duffy to act as the Chief Executive Officer of the Company and AAT, with an annual base salary of $180,000 (subject to increases at the discretion of the Board of Directors) and the issuance of 1,000,0001,000 Series ~~B Preferred Shares. The Agreement provided that the term thereof commenced on May 12, 2021 and will end on December 31, 2022.~~

~~On May 12, 2021, the Company appointed Scott Duffy as director to fill a vacancy on the Board of Directors.~~

~~On May 14, 2021, the Company appointed Michael Harper and Lisa Ruth as directors to fill two additional vacancies on the Board of Directors.~~A preferred stock.

The following discussion of our financial condition and results of operations should be read in conjunction with the audited and unaudited financial statements and the notes to those statements included elsewhere in this Report. This discussion contains forward-looking statements that involve risks and uncertainties. You should specifically consider the various risk factors identified in this Report that could cause actual results to differ materially from those anticipated in these forward-looking statements.

This Quarterly Report on Form 10-Q contains forward looking statements, including without limitation, statements related to our plans, strategies, objectives, expectations, intentions and adequacy of resources. Investors are cautioned that such forward-looking statements involve risks and uncertainties including without limitation the following: (i) our plans, strategies, objectives, expectations and intentions are subject to change at any time at our discretion; (ii) our plans and results of operations will be affected by our ability to manage growth; and (iii) other risks and uncertainties indicated from time to time in our filings with the Securities and Exchange Commission.

In some cases, you can identify forward-looking statements by terminology such as ‘‘may,’’ ‘‘will,’’ ‘‘should,’’ ‘‘could,’’ ‘‘expects,’’ ‘‘plans,’’ ‘‘intends,’’ ‘‘anticipates,’’ ‘‘believes,’’ ‘‘estimates,’’ ‘‘predicts,’’ ‘‘potential,’’ or ‘‘continue’’ or the negative of such terms or other comparable terminology. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance, or achievements. Moreover, neither we nor any other person assumes responsibility for the accuracy and completeness of such statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. We are under no duty to update any of the forward-looking statements after the date of this Report.

This section of the report should be read together with Footnotes of the Company audited financials for the year ended June 30, ~~2020.~~2021. The unaudited statements of operations for the ~~nine~~three and six months ended ~~March~~December 31, 2021 and 2020 are compared in the sections below.

Xeriant ~~Inc.~~ is aan aerospace technology and advanced materials holding and operating company focused on ~~acquiring,~~Advanced Air Mobility (“AAM”) and the transition to green aerospace. The Company plans to source and acquire complementary and strategic interests in visionary companies developing, integrating, and commercializing critical breakthrough technologies ~~with applications in aerospace,~~which enhance performance, increase safety, and enable and support more efficient, autonomous, and sustainable flight operations, including ~~innovative~~electrically powered passenger and cargo transport aircraft ~~concepts.~~capable of vertical takeoff and landing. The Company is located at the Research Park at Florida Atlantic University in Boca Raton, Florida.

The Company was originally incorporated in Nevada on December 18, ~~2009.~~ 2009 under the name Eastern World Solutions, Inc. The name changed to Banjo & Matilda, Inc. on September 24, 2013. Effective June 22, 2020 the Company changed its name from Banjo & Matilda, Inc. to Xeriant, Inc.

On April 16, 2019, ~~Xeriant~~the Company entered into a Share Exchange Agreement with American Aviation Technologies, LLC (“AAT”), an aircraft design and development company focused on the emerging segment of the aviation industry of autonomous and semi-autonomous vertical take-off and landing (VTOL) and unmanned aerial vehicles (UAVs).

On June 28, 2019, the Company spun out two wholly owned subsidiaries: Banjo & Matilda (USA), Inc. and Banjo & Matilda Australia Pty LTD.

On September 30, 2019, the acquisition of AAT closed, and AAT became a wholly owned subsidiary of the Company.

On June 22, 2020, the name was changed from Banjo & Matilda, Inc. to Xeriant, Inc.

~~Effective June 22, 2020~~On May 27, 2021, the Company ~~changed its name~~entered into a Joint Venture Agreement with XTI Aircraft Company, to ~~Xeriant, Inc.~~form a new company, called Eco-Aero, LLC, for purpose of completing the preliminary design of XTI’s TriFan 600, a 5-passenger plus pilot, hybrid electric, vertical takeoff and ~~the name and symbol change were approved by FINRA effective July 30, 2020.~~landing (eVTOL) fixed wing aircraft.

On ~~April 16, 2019, Xeriant, Inc. and~~May 31, 2021, the ~~members of American Aviation Technologies, LLC (“AAT”)~~Company entered into a ~~Share Exchange~~Joint Venture Agreement ~~(the “Agreement”). AAT,~~with XTI Aircraft Company, to form a ~~Florida limited liability~~new company, ~~is an aircraft~~called Eco-Aero, LLC, for purpose of completing the preliminary design of XTI’s TriFan 600, a 5-passenger plus pilot, hybrid electric, vertical takeoff and development company dedicated to advancing aeronautical safety and performance through new and innovative concepts. The agreement, which became effective on September 30, 2019, was pursuant to which Xeriant acquired 100% of the issued and outstanding membership units in exchange for the issuance of Xeriant Series A Preferred Stock constituting 86.39% of the total voting power of Xeriant capital stock to be outstanding upon closing, after giving effect to the consummation of concurrent debt settlement and other capital stock issuances but before the issuance of shares of capital stock for investor relations purposes. As a result of the Exchange Agreement, AAT became a wholly owned subsidiary of Xeriant.

~~The Exchange Agreement was subject to the satisfaction of certain conditions as set forth in the Exchange Agreement.~~

Between February 11 and March 19, 2021, the Company was engaged in discussions with former members of American Aviation Technologies, LLC (“AAT”) regarding the breach by such members of material provisions of the Share Exchange Agreement dated September 30, 2019 pursuant to which the Company acquired AAT. As a result of these negotiations and the acknowledgement by certain former members of such breach, such members agreed to return an aggregate of 1,250,001 Series A Preferred Shares to the treasury of the Company. Additionally, the Company canceled 990,000 Series A Preferred Shares allocated to Russell Randall, a former member of AAT.

Three months ended ~~March~~December 31, 2021 compared to the three months ended ~~March~~December 31, 2020

Total general and administrative expenses were $141,897 for the three months ended March 31, 2021 compared to $73,409 for the three months ended March 31, 2020. The increase of $68,488 primarily relates to additional Company costs such as insurance expenses, advisory board fees and corporate listing expenses.

Total professional fees were $32,160 for the three months ended March 31, 2021 compared to $48,250 for the three months ended March 31, 2020. The decrease of $16,090 primarily is due to additional accounting expenses incurred in the period ended March 31, 2020 related to the filing of delinquent SEC reports.

Total related party consulting fees were $54,500 for the three months ended March 31, 2021 compared to $0 for the three months ended March 31, 2020. The increase of $54,500 was because fees incurred by related parties did not begin until the quarter ended June 30, 2020.

Total other expenses were $105,886 for the three months ended March 31, 2021 compared to $171,301 for the three months ended March 31, 2020. Total other expenses consist of interest expense on debt and amortization of debt. The decrease of $65,415 was related to due to higher amortization of debt discount in the prior period.

Total net loss was $334,443 for the three months ended March 31, 2021 compared to $292,960 for the three months ended March 31, 2020. The increase of $41,483 was primarily due to related party consulting fees and higher General and administrative expenses.

~~Nine months ended March 31, 2021 compared to the nine months ended March 31, 2020~~

	For the nine months ended												For the three months ended
	March 31, 2021			March 31, 2020			$			%			December 31, 2021			December 31, 2020			$			%

Operating expenses:
Sales and marketing expense	$	1,000,000		$	-		$	1,000,000			100	%	$	46,623		$	1,027,109		$	(980,486	)		95	%
General and administrative expenses		242,445			141,945			100,500			71	%		1,120,250			37,469			1,082,781			2889.80	%
Professional fees		67,397			114,668			(47,271	)		-41	%		102,484			14,637			87,848			600.18	%
Related party consulting fees		132,500			-			132,500			100	%		130,925			41,500			89,425			215.48	%
Research and development expense		-			6,339			(6,339	)		-100	%		2,859,644			-			2,859,644			100	%
Total operating expenses		1,442,342			262,952			1,179,390			130	%		4,259,926			1,120,715			3,139,211			280.11	%

Loss from operations		(1,442,342	)		(262,952	)		(1,179,390	)		449	%		(4,259,926	)		(1,120,715	)		3,139,211			280.11	%

Other income (expense):
Amortization of debt discount		(215,635	)		(286,375	)		70,740			100	%		(1,264,931	)		(66,449	)		(1,198,482	)		1,803.61	%
Amortization of debt discount, related party		(5,000	)		(27,242	)		22,242			200	%		-			(3,044	)		3,044			100	%
Interest expense		(4,857	)		(8,609	)		3,752			-44	%		(1,625	)		(1,139	)		(486	)		42.67	%
Interest expense, related parties		(76	)		(3,979	)		3,903			-98	%		-			(46	)		(46	)		100	%
Gain on forgiveness of accounts payable														-			(1,956	)		1,956			100	%
Loss on settlement of debt		(186,954	)		-			(186,954	)		100	%		(4	)		-			(4	)		100	%
Total other income (expense)		(412,522	)		(326,205	)		(86,317	)		26	%		(1,266,560	)		(72,634	)		(1,193,926	)		1,643.76	%

Net loss	$	(1,854,864	)	$	(589,157	)	$	(1,265,707	)		215	%	$	(5,526,486	)		(1,193,349	)		(4,333,137	)		363.11	%

Sales and marketing expense was ~~$1,000,000~~$46,623 for the ~~nine~~three months ended ~~March~~December 31, 2021 compared to $0$1,027,109 for the ~~nine~~three months ended ~~March~~December 31, 2020. During the ~~nine~~three months ended ~~March~~December 31, 2021, the Company ~~issued 20,000,000 shares valued at $1,000,000 for~~was putting less money into investor ~~relation services.~~relationship to market the Company.

Total general and administrative expenses were ~~$242,445~~$1,120,250 for the ~~nine~~three months ended ~~March~~December 31, 2021 compared to ~~$141,945~~$37,469 for the ~~nine~~three months ended ~~March~~December 31, 2020. The increase of ~~$100,500~~$1,082,781 primarily relates to ~~additional Company costs such as insurance expenses,~~options valued at $827,221 for advisory board ~~fees and corporate listing expenses.~~services.

Total professional fees were ~~$67,397~~$102,484 for the ~~nine~~three months ended ~~March~~December 31, 2021 compared to ~~$114,668~~$14,637 for the ~~nine~~three months ended ~~March~~December 31, 2020. The ~~decrease~~increase of ~~$47,271 is due~~$87,847 primary relates to ~~additional accounting expenses incurred in the period ended March 31, 2020 related to the filing of delinquent SEC reports as well as engineering and~~ legal fees.

Total related party consulting fees were ~~$132,500~~$130,925 for the ~~nine~~three months ended ~~March~~December 31, 2021 compared to $0$41,500 for the ~~nine~~three months ended ~~March~~December 31, 2020. The increase of ~~$132,500~~$89,425 was ~~because fees incurred by~~primarily related ~~parties didn’t begin until~~to $28,000 in new related party expenses coupled with an increase in the ~~quarter ended March 31, 2020.~~pay of existing related party.

Total research and development expenses were $0$2,859,644 for the ~~nine~~three months ended ~~March~~December 31, 2021 compared to ~~$6,339~~$0 for the ~~nine~~three months ended ~~March~~December 31, 2020. The ~~decrease of 100% was due to the fact there were no~~ research and development ~~projects~~costs were mainly related to the development of an aircraft through our Eco-Aero joint venture and $92,746 expenditure to Movychem, a Slovakian limited liability company for research and development in ~~the current period.~~advanced materials and chemicals.

Total other ~~expenses~~income (expenses) were ~~$412,522~~($1,266,560) for the ~~nine~~three months ended ~~March~~December 31, 2021 compared to ~~$326,205~~($72,634) for the ~~nine~~three months ended ~~March~~December 31, 2020. Total other expenses consist of interest expense on debt, amortization of debt and loss on settlement of debt. The increase of ~~$86,317~~$1,193,926 was primarily related ~~a loss on settlement~~the Company recording amortization of ~~debt.~~debt discount during the three months ended December 31, 2021 in the amount of $1,264,931.

Total net loss was ~~$1,854,864~~$5,526,486 for the ~~nine~~three months ended ~~March 31,~~December 30, 2021 compared to ~~$589,157~~$1,193,349 for the ~~nine~~three months ended ~~March~~December 31, 2020. The increase of ~~$1,265,707~~$4,333,137 was primarily due to research and development expenses of $2,766,898 and equity based compensation of $943,326.

Six months ended December 31, 2021 compared to the six months ended December 31, 2020

Sales and marketing expense was $645,218 for the six months ended December 31, 2021 compared to $1,027,109 for the six months ended December 31, 2020. During the six months ended December 31, 2021, the Company was putting money into sales and marketing expenses to actively market the brand.

Total general and administrative expenses were $2,321,252 for the six months ended December 31, 2021 compared to $73,439 for the six months ended December 31, 2020. The increase of $2,247,813 primarily relates to options valued at $1,887,545 for advisory board services and $657,204 from stock issued for services.

Total professional fees were $132,025 for the six months ended December 31, 2021 compared to $35,237 for the six months ended December 31, 2020. The increase of $96,789 primary relates to legal fees.

Total related party consulting fees ~~higher general~~were $213,425 for the six months ended December 31, 2021 compared to $78,000 for the six months ended December 31, 2020. The increase of $135,425 was primarily related to $28,000 in new related party expenses coupled an increase in the pay of existing related party.

Total research and development expenses were $5,200,219 for the six months ended December 31, 2021 compared to $0 for the six months ended December 31, 2020. The research and ~~shares issued~~development costs were related to the development of an aircraft through our Eco-Aero joint venture and $142,790 expenditure to Movychem, a Slovakian limited liability company for ~~investor relations.~~research and development in advanced materials and chemicals.

Total other income (expenses) were ($1,462,259) for the six months ended December 31, 2021 compared to ($306,636) for the six months ended December 31, 2020. Total other expenses consist of interest expense on debt, amortization of debt and loss on settlement of debt. The increase of $1,155,623 was primarily related the Company recording amortization of debt discount during the six months ended December 31, 2021 in the amount of $1,413,959.

Total net loss was $9,974,398 for the six months ended December 30, 2021 compared to $1,520,421 for the six months ended December 31, 2020. The increase of $8,453,977 was primarily due to research and development expenses of $5,200,219 and equity based compensation of $2,544,750.

Cash used in operations of ~~$370,177~~$6,013,001 during the ~~nine~~six months ended ~~March~~December 31, 2021 was primarily resulted from the increase cash used in operations resulted from increased expenditures on research and development expense. The Company has a ~~result of our $1,854,864~~ net loss ~~reconciled with our net~~of $9,974,398 during the six months ended December 31, 2021 and offset by non-cash expenses ~~relating to~~such as stock compensation expense of $1,887,545, stock issued for services of $657,204, and amortization of debt ~~discount, loss on settlement~~discounts of ~~debt, and our changes in operating assets and liabilities relating to prepaid expenses and accounts payable and accrued liabilities.~~ $1,413,959.

Cash used in operations of ~~$237,674~~$162,557 during the ~~nine~~six months ended ~~March~~December 31, 2020 was primarily a result of our ~~$589,157~~$1,520,421 net loss reconciled with our net non-cash expenses relating to amortization of debt discount and our changes in operating assets and liabilities relating to accounts payable and accrued liabilities.

Net cash used in investing activities for the six months ended December 31, 2021 was $4,990, which consisted of purchase of new equipment.

Net cash provided by financing activities for the ~~nine~~six months ended ~~March~~December 31, 2021 was ~~$1,837,850,~~$7,166,000, which consisted of proceeds from the sale of common stock of ~~$1,548,000~~$2,078,500, cash in the amount of $128,550 from the exercise of warrants, and issuance of convertible debt of ~~$289,850.~~ $4,958,950.

Net cash provided by financing activities for the ~~nine~~six months ended ~~March~~December 31, 2020 was ~~$372,950,~~$143,300, which consisted of proceeds from the sale of common stock of $51,000 and issuance of convertible debt ~~in the amount~~ of ~~$339,950 and from the issuance of convertible debt, related party in the amount of $33,000.~~$92,300.

The ~~Company's~~Company’s financial statements are prepared using the generally accepted accounting principles applicable to a going concern, which contemplates the realization of assets and liquidation of liabilities in the normal course of business. At ~~March~~December 31, 2021 and June 30, ~~2020,~~2021, the Company had ~~$1,506,566~~$2,110,549 and ~~$38,893~~$962,540 in cash and ~~$1,393,092~~$1,305,399 and $677,257 in ~~working capital and $53,532 in negative~~ working capital, respectively. For the ~~nine~~six months ended ~~March~~December 31, 2021 and 2020, the Company had a net loss of ~~$1,854,864~~$9,974,398 and ~~$334,443,~~$1,520,421, respectively. Continued losses may adversely affect the liquidity of the Company in the future. Therefore, the factors noted above raise substantial doubt about our ability to continue as a going concern. The recoverability of a major portion of the recorded asset amounts shown in the accompanying balance sheets is dependent upon continued operations of the Company, which in turn is dependent upon the ~~Company's~~Company’s ability to raise additional capital, obtain financing and to succeed in its future operations. The financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern. The Company’s existence is dependent upon management’s ability to develop profitable operations and resolve its liquidity problems.

To date, our operations have been funded primarily through private investors. ~~Some of these investors have verbally committed additional funding for the Company, as needed.~~ We have had a number of discussions with ~~broker-dealers regarding the funding required to execute the Company’s business plan,~~investment banker and institutional investment, which is to acquire and develop breakthrough technologies or business interests in those companies that have developed these technologies. ~~We are in the process of issuing an offering document to obtain the funding for certain acquisitions that are in the discussion stages.~~ There is no assurance that the Company will be able to obtain such funding and/or working capital. To the extent that funding is not available, the Company will be required to scale back or discontinue its business plan. Even if the Company is able to obtain financing, it may contain undue restrictions of the Company’s operations, or there may be substantial dilution for our shareholders in the case of equity financing or convertible debt financing.

We do not have any off-balance sheet arrangements, financings, or other relationships with unconsolidated entities or other persons, also known as “special purpose entities” (SPEs).

In the ordinary course of our business, we are not exposed to market risk of the sort that may arise from changes in interest rates or foreign currency exchange rates, or that may otherwise arise from transactions in derivatives.

Certain conditions may exist as of the date the financial statements are issued, which may result in a loss to the Company, but which will only be resolved when one or more future events occur or fail to occur. Our management, in consultation with its legal counsel as appropriate, assesses such contingent liabilities, and such assessment inherently involves an exercise of judgment. In assessing loss contingencies related to legal proceedings that are pending against us or unasserted claims that may result in such proceedings, we, in consultation with legal counsel, evaluates the perceived merits of any legal proceedings or unasserted claims, as well as the perceived merits of the amount of relief sought or expected to be sought therein. If the assessment of a contingency indicates it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in our financial statements. If the assessment indicates a potentially material loss contingency is not probable, but is reasonably possible, or is probable, but cannot be estimated, then the nature of the contingent liability, together with an estimate of the range of possible loss, if determinable and material, would be disclosed. Loss contingencies considered remote are generally not disclosed unless they involve guarantees, in which case the guarantees would be disclosed.

As a smaller reporting company, the Company has elected not to provide the disclosure required by this item.

Our management is responsible for maintaining disclosure controls and procedures that are designed to ensure that information required to be disclosed in the reports that the Registrant files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the ~~SEC's~~SEC’s rules and forms. In addition, the disclosure controls and procedures must ensure that such information is accumulated and communicated to the ~~Registrant's~~Registrant’s management, including its Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required financial and other required disclosures.

At ~~March~~December 31, 2021, an evaluation of the effectiveness of our disclosure controls and procedures (as defined in Rules 13(a)-15(e) and 15(d)-15(e) of the Exchange Act) was carried out under the supervision and with the participation of Keith Duffy our Chief Executive Officer and Brian Carey our Chief Financial Officer. Based on his evaluation of our disclosure controls and procedures, he concluded that at ~~March~~December 31, 2021, our disclosure controls and procedures are not effective due to material weaknesses in our internal controls over financial reporting discussed directly below.

There has been no change in the Company’s internal control over financial reporting, as defined in Rules 13a-15(f) of the Exchange Act, during the Company’s most recent fiscal quarter ended ~~March~~December 31, 2021, that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.

Our business is subject to numerous risks and uncertainties including but not limited to those discussed in “Risk Factors” in our Annual Report on Form 10-K.

During the three months ended September 30, 2021, the Company issued 400,000 shares of common stock related to a subscription agreement from the previous fiscal year, which were previously recorded in common stock to be issued at $48,000.

During the three months ended September 30, 2021, the Company sold 2,500,000 shares of common stock for aggregate proceeds of $250,000, or $0.10 per share.

During the three months ended September 30, 2021, the Company sold 5,000,000 shares of common stock for aggregate proceeds of $250,000, or $0.05 per share.

In connection with one of the subscription agreements, the Company issued 250,000 shares as an equity kicker valued at $43,750, which has been expensed as a financing costs.

During the three months ended September 30, 2021, the Company issued 4,185,000 shares of common stock as a result of warrant exercises in the aggregate proceeds of $125,550.

During the three months ended September 30, 2021, the Company issued 4,000,000 shares of common stock in exchange for the conversion of 4,000 shares of Series A Preferred Stock.

During the three months ended September 30, 2021, the Company issued 10,598,544 shares of common stock for the conversion of $167,550 in principal and $4,985 in accrued interest. This resulted in a loss on extinguishment of debt in the amount of $535.

During the three months ended September 30, 2021, the Company issued 2,825,000 shares of common stock for services, valued at $449,200.

During the three months ended December 31, 2021, the Company sold 8,200,000 shares of common stock for aggregate proceeds of $410,000, or $0.05 per share.

During the three months ended December 31, 2021, the Company issued 23,266,667 shares of common stock for aggregate proceeds of $1,162,500, or $0.05 per share for the sale of common shares that has not been issued in the quarter ended September 30, 2021.

During the three months ended December 31, 2021, the Company issued 4,305,000 shares of common stock for the $3,000 exercise of warrants in the quarter ended September 30, 2021.

During the three months ended December 31, 2021, the Company issued 3,138,000 shares of common stock in exchange for the conversion of 3,318 shares of Series A Preferred Stock.

During the three months ended December 31, 2021, the Company issued 900,000 shares of common stock for services, valued at $116,105.

In accordance with the requirements of the Exchange Act, the Company caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Nevada		27-1519178
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification No.)

Innovation Centre #1 3998 FAU Boulevard, Suite 309 Boca Raton, Florida		33431
(Address of principal executive offices)		~~33431~~
~~(Address of principal executive offices)~~		(Zip code)

		Page

Special Note regarding Forward-looking Statements			3

PART I – FFinancial Information~~inancial Information~~

Item 1.	Condensed Consolidated Financial Statements (Unaudited)		4
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations		5
Item 3.	Quantitative and Qualitative Disclosures about Market Risk		10
Item 4.	Controls and Procedures		10

PART II – Other Information

Item 1.	Legal Proceedings		11
Item 1A.	Risk Factors		11
Item 2.	Unregistered Sales of Equity Securities		11
Item 3.	Defaults Upon Senior Securities		11
Item 4.	Mine Safety Disclosures		11
Item 5.	Other Information		11
Item 6.	Exhibits		12

Signatures
~~Signatures~~			13

Condensed Consolidated Balance Sheets as of ~~March~~December 31, 2021 (Unaudited) and June 30, ~~2020~~2021		F-1

Condensed Consolidated Statements of Operations for the three and ~~nine~~six months ended ~~March~~December 31, 2021 and 2020 (Unaudited)		F-2

Condensed Consolidated Statements of Stockholder’s Deficit for the ~~nine~~three and six months ended ~~March~~December 31, 2021 and 2020 (Unaudited)		F-3

Condensed Consolidated Statements of Cash Flows for the six months ended December 31, 2021 and 2020 (Unaudited)	F-5

Notes to Unaudited Condensed Consolidated Financial Statements		F-6

XERIANT, INC.
CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' DEFICIT
FOR THE THREE AND NINE MONTHS ENDED MARCH 31, 2021

											Additional			Common
	Preferred Stock						Common Stock				Paid in			stock to be			Accumulated
	Shares			Amount			Shares		Amount		Capital			issued			Deficit			Total
Balance June 30, 2020		3,113,638		$	31			69,584,149	$	696	$	379,971		$	372,397		$	(784,319	)	$	(31,224	)

Shares reclassed from common stock to be issued		-			-			112,847,466		1,127		371,270			(372,397	)		-			-
												��
Conversion of convertible notes and accrued interest		-			-			-		-		-			51,145			-			51,145

Conversion of Series A Preferred to Common Stock		(39,358	)		-			39,358,000		393		(393	)		-			-			-

Issuance of warrants with convertible notes		-			-			-		-		36,407			-			-			36,407

Fair value of beneficial conversion feature associated with convertible debt		-			-			-		-		42,893			-			-			42,893

Stock issued for services		-			-			4,090,909		40		200,414			-			-			200,454

Net Loss		-			-			-		-		-			-			(327,072	)		(327,072	)

Balance September 30, 2020		3,074,280			31			225,880,524		2,256		1,030,562			51,145			(1,111,391	)		(27,397	)

Sale of common stock		-			-			3,400,000		34		50,966			-			-			51,000

Conversion of convertible notes and accrued interest		-			-			-		-		-			78,714			-			78,714

Issuance of warrants with convertible notes		-			-			-		-		6,388			-			-			6,388

Fair value of beneficial conversion feature associated with convertible debt		-			-			-		-		6,612			-			-			6,612

Stock issued for services		-			-			20,300,000		203		1,012,997			-			-			1,013,200

Issuance of warrants for services		-			-			-		-		13,909			-			-			13,909

Net Loss		-			-			-		-		-			-			(1,193,349	)		(1,193,349	)

Balance December 31, 2020		3,074,280		$	31			249,580,524	$	2,493	$	2,121,434		$	129,859		$	(2,304,740	)	$	(50,923	)

Cancellation of Series A Preferred shares		(2,240,000	)		(22	)		-		-		22			-			-			-

Cancellation of Series A Preferred shares		(41,001	)		(1	)		-		-		1			-			-			-

Sale of common stock		-			-			9,991,667		100		1,198,900			298,000			-			1,497,000

Shares reclassed from common stock to be issued		-			-			19,595,442		195		129,660			(129,859	)		-			(4	)

Conversion of convertible notes and accrued interest		-			-			4,557,943		46		23,810			-			-			23,856

Issuance of warrants with convertible notes		-			-			-		-		75,097			-			-			75,097

Fair value of beneficial conversion feature associated with convertible debt		-			-			-		-		122,453			-			-			122,453

Stock issued for services		-			-			150,000		2		62,048			-			-			62,050

Issuance of warrants for services		-			-			-		-		24,422			-			-			24,422

Net Loss		-			-			-		-		-			-			(334,443	)		(334,443	)
Balance March 31, 2021		793,279		$	8			283,875,576	$	2,836	$	3,757,847		$	298,000		$	(2,639,183	)	$	1,419,508

	Series A Preferred Stock					Series B Preferred Stock				Common stock				Additional Paid in			Stock			Accumulated			Non-Controlling
	Shares			Amount		Shares		Amount		Shares		Amount		Capital						Deficit			Interest			Total

Balance June 30, 2021		788,270			8		1,000,000		10		292,815,960		2,925	$	4,138,194		$	51,090		$	(3,270,235	)	$	(216,686	)	$	705,306

Issuance of common stock committed in prior period		0			0		0		0		400,000		4		47,996			(48,000	)		0			0			0

Sale of common stock		0			0		0		0		7,500,000		75		499,925			1,168,500			0			0			1,668,500

Shares issued as equity kicker		0			0		0		0		250,000		3		43,750			0			0			0			43,753

Exercise of warrants		0			0		0		0		4,185,000		41		125,509			3,000			0			0			128,550

Conversion of Series A Preferred to Common Stock		(4,000	)		0		0		0		4,000,000		40		(40	)		0			0			0			0

Conversion of convertible notes and accrued interest		0			0		0		0		10,598,544		106		176,054			(3,090	)		0			0			173,070

Stock issued for services		0			0		0		0		2,825,000		27		449,173			91,900			0			0			541,100

Stock option compensation		-			0		-		0		-		0		1,060,324			0			0			0			1,060,324

Fair value of beneficial conversion feature associated with convertible debt		-			0		-		0		-		0		250,000			0			0		0				250,000

Net Loss		-			0		-		0		-		0		0			0			(3,270,099	)		(1,177,816	)		(4,447,915	)

Balance September 30, 2021		784,270		$	8		1,000,000	$	10		322,574,504	$	3,221	$	6,790,885		$	1,263,400		$	(6,540,334	)	$	(1,394,502	)	$	122,688

Issuance of common stock committed in prior period		0			0		0		0		23,266,666		233		1,162,267			(1,162,500	)		0			0			0

Sale of common stock		0			0		0		0		8,200,000		82		409,918			0			0			0			410,000

Exercise of warrants		0			0		0		0		123,600		1		2,999			(3,000	)		0			0			0

Conversion of Series A Preferred to Common Stock		(3,138	)		0		0		0		3,138,000		31		(31	)		0			0			0			0

Conversion of convertible notes and accrued interest		-			0		-		0		-		0		0			250,000			0			0			250,000

Stock issued for services		0			0		0		0		900,000		9		116,095			0			0			0			116,104

Stock option compensation		-			0		-		0		-		0		827,221			0			0			0			827,221
Fair value of warrants associated with convertible debt		-			0		-		0		-		0		2,777,081			0			0		0				2,777,081

Fair value of beneficial conversion feature associated with convertible debt		-			0		-		0		-		0		2,365,419			0			0		0				2,365,419

Net Loss		-			0		-		0		-		0		0			0			(3,489,430	)		(2,037,053	)		(5,526,483	)

Balance December 31, 2021		781,132		$	8		1,000,000	$	10		358,202,770	$	3,577	$	14,451,855		$	347,900		$	(10,029,764	)	$	(3,431,555	)	$	1,342,031

Large accelerated filer	☐	Accelerated filer	☐
Non-accelerated ~~filer~~Filer	☐	Smaller reporting company	☒
Emerging growth company	☐

	(i)	persuasive evidence of an arrangement exists,
	(ii)	the services have been rendered and all required milestones achieved,
	~~(ii)~~(iii)	the ~~services have been rendered~~sales price is fixed or determinable, and ~~all required milestones achieved,~~
	~~(iii)~~	~~the sales price is fixed or determinable, and~~
	(iv)	Collectability is reasonably assured.

	Base
Rent Periods	Rent
February 1, 2020 to October 1, 2020	$	4,367
November 1, 2020 to October 1, 2021	$	4,498
November 1, 2021 to October 1, 2022	$	4,633
November 1, 2021 to October 1, 2022	$	4,771
November 1, 2023 to October 1, 2024	$	4,915
November 1, 2024 to January 1, 2025	$	5,063

	March 31, 2021
Office lease	$	193,535
Less: current portion		(41,165	)
Long term portion		152,370

Maturity of the lease liability is as follows:
Fiscal year ending June 30, 2021	$	14,370
Fiscal year ending June 30, 2022		58,635
Fiscal year ending June 30, 2023		60,392
Fiscal year ending June 30, 2024		62,201
Fiscal year ending June 30, 2025		37,112
		232,710
Present value discount		(39,175	)
Lease liability	$	193,535

	December 31, 2021
Office lease	$	163,305
Less: current portion		(45,720	)
Long term portion		117,585

Fiscal year ending June 30, 2022	$	29,607
Fiscal year ending June 30, 2023		60,392
Fiscal year ending June 30, 2024		62,201
Fiscal year ending June 30, 2025		37,112
		189,312
Present value discount		(26,007	)
Lease liability	$	163,305

	March 31,			June 30,
Convertible Notes Payable	2021			2020
Convertible notes payable issued March 2, 2020 (6% interest)	$	-		$	22,000
Convertible notes payable issued March 3, 2020 (6% interest)		-			10,000
Convertible notes payable issued March 7, 2020 (6% interest)		-			1,650
Convertible notes payable issued March 10, 2020 (6% interest)		-			15,000
Convertible notes payable issued April 9, 2020 (6% interest)		-			1,000
Convertible notes payable issued April 23, 2020 (6% interest)		-			2,000
Convertible notes payable issued May 11, 2020 (6% interest)		-			1,500
Convertible notes payable issued December 2, 2020 (6% interest)		3,000			-
Convertible notes payable issued January 4, 2021 (6% interest)		20,000			8,000
Convertible notes payable issued January 5, 2021 (6% interest)		25,000			8,000
Convertible notes payable issued January 11, 2021 (6% interest)		142,550			8,000
Convertible notes payable issued January 19, 2021 (6% interest)		10,000			-
Total face value		200,550			61,150
Less unamortized discount		(97,630	)		(28,416	)
Carrying value	$	102,920		$	32,734

	·	to issue 500,000 shares payable at the date of the agreement, 500,000 shares payable three months from the date of the agreement, 500,000 shares payable six months from the date of the agreement.

	·	Pay a financing fee of 1.5% of gross proceeds received by the Company up to $100,000,000; a financing fee of 1.25% of gross proceeds received by the Company from $100,000,000-$200,000,000, and a financing fee of 1% of gross proceeds received by the Company over $200,000,000

	·	M&A fee of 1.5% of the value of a business or asset sold up to $50,000,000; an M&A fee of 1.25% of value of a business or asset sold from $50,000,000-$100,000,000, an M&A fee of 1% of value of a business or asset sold from $100,000,000-$200,000,000, and an M&A fee of 0.5% of value of a business or asset sold over $200,000,000

	·	Issue 2,225,000 common shares payable at the date of the agreement, and 2,225,000 common shares payable upon an uplisting of the Company’s common stock to a national exchange.

	·	Pay a cash fee of seven percent 7% of the amount of capital raised, invested or committed; and deliver a warrant (the “Agent Warrant”) to purchase shares of the Common Stock equal to seven percent (7%) of the number of shares of Common Stock underlying the securities issued in the Financing.

	·	Pay a cash fee for entering into a transaction including, without limitation, a merger, acquisition or sale of stock or assets equal to one and one half percent (1.5%), or in the event a transaction is consummated with a party that was in communication with the Company prior to the date of this contract, then the fee shall equal one half percent (0.5%).

·	Voting: The preferred shares shall be entitled to 100 votes to every one share of common stock.

·	Dividends: The Series A Preferred Stockholders are treated the same as the Common Stock holders except at the dividend on each share of Series A Convertible Preferred Stock is equal to the amount of the dividend declared and paid on each share of Common Stock multiplied by the Conversion Rate.

·	Conversion: Each share of Series A Preferred Stock is convertible, at the option of the holder thereof, at any time into shares of Common Stock on a 1:1,000 basis.

·	The shares of Series A Preferred Stock are redeemable at the option of the Corporation at any time after September 30, 2022 upon not less than 30 days written notice to the holders. It is not mandatorily redeemable.	The shares of Series A Preferred Stock are redeemable at the option of the Corporation at any time after September 30, 2022 upon not less than 30 days written notice to the holders. It is not mandatorily redeemable.

Quoted market price on valuation date	$0.169 - $0.23
Exercise prices	$	0.12
Range of expected term	1.55 Years – 2.49 Years
Range of market volatility:
Range of equivalent volatility	215.12%-275.73		%
Range of interest rates	0.20%-0.47		%

Exhibit Number		Document

4.1		Senior Secured Promissory Note *

4.2		Warrant *

10.1		Securities Purchase Agreement *

10.2		Security Agreement *

31.1		~~Certifications~~Certification of the principal executive officer ~~and~~pursuant to Rule 13a-14(a) or 15d-14(a) under the Securities Exchange Act of 1934, as amended, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

31.2		Certification of the principal financial officer pursuant to Rule 13a-14(a) or 15d-14(a) under the Securities Exchange Act of 1934, as amended, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

32.1		~~Certifications~~Certification of the principal executive officer ~~and~~pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

32.2		Certification of the principal financial officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.


101.INS		Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document).

101.SCH		Inline XBRL Taxonomy Extension Schema Document

101.CAL		Inline XBRL Taxonomy Extension Calculation Linkbase Document

101.DEF		Inline XBRL Taxonomy Extension Definition Document

101.LAB		Inline XBRL Taxonomy Extension Label Linkbase Document

101.PRE		Inline XBRL Taxonomy Extension Presentation Linkbase Document

104		Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)

	XERIANT, INC.

Date: ~~May 24, 2021~~February 14, 2022	By:	/s/ Keith Duffy
		Keith Duffy Chief Executive Officer (Principal Executive)